DiaphOne Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 1

DiaphOne Therapeutics General Information

Description

Developer of small molecule inhibitors designed to treat diabetic nephropathy and other diabetic complications. The company's platform focuses on the intracellular RAGE-Diaph1 interface, enabling doctors with the treatment of diabetic nephropathy and other diseases such as ALS, Alzheimer's, and breast cancer with more direct, organ-specific intervention.

Contact Information

Website
www.diaphonetx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Paasheuvelweg 25
  • 1105 BP Amsterdam
  • Netherlands
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Paasheuvelweg 25
  • 1105 BP Amsterdam
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DiaphOne Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 23-Oct-2024 Completed Startup
To view DiaphOne Therapeutics’s complete valuation and funding history, request access »

DiaphOne Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
NLC Health Ventures Venture Capital Minority
To view DiaphOne Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

DiaphOne Therapeutics FAQs

  • When was DiaphOne Therapeutics founded?

    DiaphOne Therapeutics was founded in 2024.

  • Where is DiaphOne Therapeutics headquartered?

    DiaphOne Therapeutics is headquartered in Amsterdam, Netherlands.

  • What industry is DiaphOne Therapeutics in?

    DiaphOne Therapeutics’s primary industry is Drug Discovery.

  • Is DiaphOne Therapeutics a private or public company?

    DiaphOne Therapeutics is a Private company.

  • What is DiaphOne Therapeutics’s current revenue?

    The current revenue for DiaphOne Therapeutics is .

  • Who are DiaphOne Therapeutics’s investors?

    NLC Health Ventures has invested in DiaphOne Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process